Ardsley Advisory Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-70,000	Closed	-$15M	–	146
2021 Q1	$15M	Buy	+70,000	New	+$15M	1.83%	16
2020 Q4	–	Sell	-3,000	Closed	-$816K	–	167
2020 Q3	$816K	Hold	3,000	–	–	0.16%	60
2020 Q2	$871K	Sell	3,000 -2,000	-40%	-$581K	0.19%	54
2020 Q1	$1.19M	Buy	5,000 +2,000	+67%	+$476K	0.47%	34
2019 Q4	$657K	Sell	3,000 -2,000	-40%	-$438K	0.1%	74
2019 Q3	$847K	Hold	5,000	–	–	0.19%	56
2019 Q2	$917K	Buy	+5,000	New	+$917K	0.14%	57
2019 Q1	–	Sell	-2,000	Closed	-$331K	–	140
2018 Q4	$331K	Sell	2,000 -4,000	-67%	-$662K	0.08%	73
2018 Q3	$1.16M	Hold	6,000	–	–	0.16%	54
2018 Q2	$1.02M	Buy	6,000 +1,000	+20%	+$170K	0.15%	61
2018 Q1	$815K	Buy	5,000 +2,500	+100%	+$408K	0.12%	63
2017 Q4	$375K	Sell	2,500 -16,000	-86%	-$2.4M	0.05%	91
2017 Q3	$2.81M	Buy	+18,500	New	+$2.81M	0.37%	52
2017 Q2	–	Sell	-7,000	Closed	-$765K	–	163
2017 Q1	$765K	Buy	+7,000	New	+$765K	0.12%	64
2016 Q3	–	Sell	-2,500	Closed	-$215K	–	196
2016 Q2	$215K	Buy	+2,500	New	+$215K	0.04%	115